Verrica Pharmaceuticals/ US92511W1080 /
| 2024-05-01 9:59:57 PM | Chg. -0.11 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 6.87USD | -1.58% | 4,445 Turnover: 30,574.19 |
-Bid Size: - | -Ask Size: - | 7.01 | 6.83 |
GlobeNewswire
04-27
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Plays...
GlobeNewswire
04-02
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Confere...
GlobeNewswire
03-26
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book L...
GlobeNewswire
02-29
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
GlobeNewswire
02-27
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire
02-22
Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
02-05
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and U...
GlobeNewswire
01-29
Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and ...
GlobeNewswire
01-05
Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potenti...
GlobeNewswire
01-04
Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical...
GlobeNewswire
01-03
Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distrib...
GlobeNewswire
2023-12-15
Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., ...
GlobeNewswire
2023-11-10
Verrica Pharmaceuticals Announces Presentation at the Jefferies Global Healthcare Conference in Lond...
GlobeNewswire
2023-10-25
Verrica Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on ...
GlobeNewswire
2023-09-27
Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) T...
GlobeNewswire
2023-08-31
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 25th Annual Global Investment...
GlobeNewswire
2023-08-29
Nufactor® Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Specialty Pharm...
GlobeNewswire
2023-08-29
FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distribut...
GlobeNewswire
2023-08-23
Verrica Issues Statement in Support of FDA’s Warning Letters to Manufacturers and Retailers for Prod...
GlobeNewswire
2022-03-02
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results
GlobeNewswire
2022-02-24
Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare Conferen...
